Brief: Atyr Pharma Gains E.U. Patent Covering Use Of Efzofitimod With Pirfenidone For Lung Inflammation Or Fibrosis
19/01/2023 13:07
Jan 19 (Reuters) - aTyr Pharma Inc LIFE.O :
* ATYR PHARMA GAINS E.U. PATENT COVERING USE OF EFZOFITIMOD
WITH
PIRFENIDONE FOR LUNG INFLAMMATION OR FIBROSIS
Source text for Eikon: ID:nGNX8YX6rs
Further company coverage: LIFE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on aTyr Pharma
See all newsBrief: Atyr Pharma Announces Research Collaboration With Montefiore Einstein
U.S. STOCKS ON THE MOVE-Charles River, Oracle, TD Synnex
US STOCKS ON THE MOVE-Charles River, Oracle, TD Synnex
U.S. STOCKS ON THE MOVE-CoreWeave, Versant Media, BlackBerry
aTyr rises as FDA aligns on late-stage lung disease study plan